Immunophenotypes of Intraductal Proliferative Lesions in Resected Specimen of Breast Carcinoma
CHEN Ting-ting,MENG Gang,GONG Xi-yu
DOI: https://doi.org/10.3969/j.issn.1001-7399.2006.01.004
2006-01-01
Experimental Pathology
Abstract:Purpose To explore the morphologic and immunophenotypic characteristics of intraductal proliferative lesions in resected specimen of breast carcinoma and their correlation with invasive carcinoma. Methods 36 cases of breast carcinoma with much tissues beside the carcinoma in resected specimen and 26 cases of benign lesions in breast were randomly selected at the same period. Expression was detected by immunohistochemical staining using antibodies to CK5, CK34βE12, S-100 protein, SMA, CK8, E-cad and c-erbB-2. Results Among the 36 cases in the group of breast carcinoma, 28 cases had intraductal proliferative lesions,separate or multiple, including 7 cases of UDH, 12 cases of CCC, 4 cases of ADH,24 cases of DCIS, 10 cases with the lesions more than two, 2 cases with all four lesions; 23 cases of UDH and 9 CCCs were contained in the control group. Immunohistochemical staining showed that CK5 was much expressed in glandular epithelial cells of florid UDH, and the expression decreased obviously to lost completely in ADH, DCIS and IDC. CK34βE12 expression was alike to CK5, but strongly than CK5, and both of them did not overlap completely. S-100 protein expressed in myoepithelial cells and proliferating glandular epithelial cells, which was alike to CK34βE12, but was negative for SMA. The myoepithelial cells were lost in reactivity to S-100 protein in 11 of 24 cases of DCIS of grade III, but kept strong positive for SMA. E-cad reappeared in DCIS and IDC, and/or the positive grades ascended. c-erbB-2 expressed clearly at membrane in DCIS of grade Ⅲ and IDC. Conclusions 77.87% IDC accompanies various intraductal proliferative lesions. Not only the morphologic changes but also immunophenotypic characteristics are different in the lesions, and the diagnosis and differential diagnosis may be made based on the above characteristics. The fact of the risk for subsequent development of invasive breast cancer from long-term follow-up studies in patients with intraductal proliferative lesions that are only treated by biopsy is not relative to the former exactly, but is more probably correlated to the residual or de novo intraductal proliferative lesions and their subsequent progression.